These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22473667)

  • 1. Three-dimensional computed tomography imaging of an implantable cardioverter-defibrillator lead fragment in the left ventricle of a heart transplant followed by successful transarterial extraction with a snare catheter.
    Luehr M; Daehnert I; Mohr FW; Barten MJ
    Interact Cardiovasc Thorac Surg; 2012 Jul; 15(1):158-60. PubMed ID: 22473667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inadvertent implantable cardioverter defibrillator lead placement in the left ventricle: long-term follow-up at nine years and management by minimally-invasive surgery.
    Defaye P; Kane A; Jacon P; Obadia J
    Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):492-3. PubMed ID: 21172950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post heart transplant extraction of the abandoned fragments of pacing and defibrillation leads: proposed management algorithm.
    Kuśmierski K; Przybylski A; Oręziak A; Sobieszczańska-Małek M; Kołsut P; Różański J
    Kardiol Pol; 2013; 71(2):159-63. PubMed ID: 23575709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image Quality of Cardiac Magnetic Resonance Imaging in Patients With an Implantable Cardioverter Defibrillator System Designed for the Magnetic Resonance Imaging Environment.
    Schwitter J; Gold MR; Al Fagih A; Lee S; Peterson M; Ciuffo A; Zhang Y; Kristiansen N; Kanal E; Sommer T;
    Circ Cardiovasc Imaging; 2016 May; 9(5):. PubMed ID: 27151268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent Bacteremia After Heart Transplantation Due to Abandoned Lead Fragment in an Anonymous Vein-A Case Report.
    Burger H; Ziegelhoeffer T; Schoenburg M; Richter M
    Transplant Proc; 2018 Dec; 50(10):4071-4074. PubMed ID: 30577318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
    Antonini L; Pasceri V; Mollica C; Ficili S; Poti G; Aquilani S; Santini M; La Rocca S
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):334-9. PubMed ID: 21487343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
    Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
    Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal management of Riata leads with no known electrical abnormalities or externalization: a decision analysis.
    Pokorney SD; Zhou K; Matchar DB; Love S; Zeitler EP; Lewis R; Piccini JP
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):184-91. PubMed ID: 25311559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
    BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Improved Left Ventricular Systolic Function on the Recurrence of Ventricular Arrhythmia in Heart Failure Patients With an Implantable Cardioverter-Defibrillator.
    Kim M; Kim J; Lee JH; Hwang YM; Kim MS; Nam GB; Choi KJ; Kim JJ; Kim YH
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1191-1198. PubMed ID: 27334231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
    Alam MB; Munir MB; Rattan R; Flanigan S; Adelstein E; Jain S; Saba S
    Europace; 2014 Feb; 16(2):246-51. PubMed ID: 24099864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation.
    Algalarrondo V; Perault R; Bories MC; Narayanan K; Garcia R; Combes N; Perier MC; Defaye P; Sadoul N; Gras D; Klug D; Bordachar P; Fauchier L; Deharo JC; Leclercq C; Boveda S; Marijon E; Babuty D;
    Arch Cardiovasc Dis; 2018 Dec; 111(12):758-765. PubMed ID: 30078651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case.
    Nakao Y; Suenari K; Yamashiro K; Nakagawa H; Shiode N
    BMC Cardiovasc Disord; 2020 Mar; 20(1):134. PubMed ID: 32169057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantation of a right ventricular implantable cardioverter-defibrillator lead in the right ventricular outflow tract in a patient with Ebstein anomaly and right ventricular lead dislocation.
    Pecha S; Yildirim Y; Hahnel F; Reichenspurner H; Aydin MA
    Thorac Cardiovasc Surg; 2014 Apr; 62(3):253-4. PubMed ID: 23258759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation.
    Black-Maier E; Lewis RK; Rehorn M; Loungani R; Friedman DJ; Frazier-Mills C; Jackson KP; Atwater BD; Milano CA; Schroder JN; Pokorney SD; Piccini JP
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1509-1518. PubMed ID: 32275340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.
    Sadoul N; Defaye P; Mouton E; Bizeau O; Dupuis JM; Blangy H; Delarche N; Blanc JJ; Lazarus A;
    Arch Cardiovasc Dis; 2013 Nov; 106(11):562-9. PubMed ID: 24200925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study.
    Hachamovitch R; Nutter B; Menon V; Cerqueira MD
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26666380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulation failure and externalized conductor of a single-coil Kentrox lead: an ongoing story?
    Bogossian H; Mijic D; Frommeyer G; Winter J
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):226-7. PubMed ID: 25302563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.